secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001493152-24-042874
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics Stockholders Approve Reverse Stock Split and Share Issuance to Alpha Capital at Annual Meeting
--------------------------------------------------------------------------------

- All five director nominees elected, each receiving over 14.3 million votes.
- Ratification of WithumSmith+Brown as auditor approved with 17,030,627 votes in favor.
- Reverse stock split (10:1 to 50:1) approved with 16,165,754 votes for, 1,435,884 against.
- Issuance of >20% common stock to Alpha Capital Anstalt approved with 14,562,299 votes for, 347,563 against, 18,595 abstaining.
- Advisory vote on executive compensation approved with 14,540,812 votes for, 297,422 against, 90,223 abstaining.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224042874/0001493152-24-042874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224042874/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer